Date published: 2026-5-3

1-800-457-3801

SCBT Portrait Logo
Seach Input

FAM22G Inhibitors

FAM22G inhibitors are a class of chemical compounds that specifically target and inhibit the function of the FAM22G protein, a member of the FAM22 family. The FAM22 family, though not extensively characterized, is believed to be involved in various cellular processes, potentially including those related to intracellular signaling, protein interactions, and the regulation of gene expression. FAM22G, like other members of this family, may play a role in maintaining cellular homeostasis and modulating pathways that are essential for proper cellular function. By inhibiting FAM22G, these compounds allow researchers to investigate the protein's specific functions and its contribution to broader biological processes within the cell. The mechanism of action for FAM22G inhibitors typically involves binding to critical domains of the FAM22G protein, such as those involved in its interaction with other proteins or its role in regulating specific cellular pathways. This binding prevents FAM22G from performing its normal functions, leading to potential disruptions in the cellular processes it influences. For example, inhibition of FAM22G could affect signaling pathways that rely on its activity, leading to changes in cellular behavior, gene expression, or protein synthesis. Additionally, FAM22G inhibitors might interfere with the protein's ability to participate in complexes or networks that are crucial for maintaining cellular integrity. The study of FAM22G inhibitors provides valuable insights into the specific roles of this protein in cellular physiology, contributing to a deeper understanding of how FAM22G and related proteins impact the regulation of cellular activities. This knowledge is essential for elucidating the molecular mechanisms that underlie cellular homeostasis and the intricate balance of signaling pathways that sustain normal cellular function.

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

A potent kinase inhibitor that can disrupt various signaling pathways which FAM22G might be part of.

Fluorouracil

51-21-8sc-29060
sc-29060A
1 g
5 g
$37.00
$152.00
11
(1)

An antimetabolite that can affect nucleotide synthesis and consequently influence pathways FAM22G is involved in.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

Histone deacetylase inhibitor that can alter chromatin structure and gene expression, potentially affecting FAM22G expression.

Taxol

33069-62-4sc-201439D
sc-201439
sc-201439A
sc-201439E
sc-201439B
sc-201439C
1 mg
5 mg
25 mg
100 mg
250 mg
1 g
$41.00
$74.00
$221.00
$247.00
$738.00
$1220.00
39
(2)

Stabilizes microtubules and can disrupt cell division, which may indirectly affect FAM22G's function if it is cell cycle-related.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

Inhibits PI3K, potentially affecting FAM22G's role in PI3K/Akt signaling pathways.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Proteasome inhibitor that can affect protein degradation pathways, possibly impacting FAM22G stability.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

Kinase inhibitor that can affect multiple signaling pathways, possibly altering FAM22G activity if it is involved in these pathways.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

Inhibits MEK, potentially disrupting the MAPK/ERK pathway which FAM22G may be a part of.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

mTOR inhibitor that can affect cellular growth and proliferation, possibly influencing the cellular context of FAM22G.

Cyclopamine

4449-51-8sc-200929
sc-200929A
1 mg
5 mg
$94.00
$208.00
19
(1)

Hedgehog signaling pathway inhibitor which could affect FAM22G if it were part of this pathway.